Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000130465 | SCV000185330 | uncertain significance | Hereditary cancer-predisposing syndrome | 2013-10-15 | criteria provided, single submitter | clinical testing | ​The p.E904Q variant (also known as c.2710G>C or 2829G>C) is located in coding exon 9 of the BRCA1 gene. This alteration results from a G to C substitution at nucleotide position 2710. The glutamic acid at codon 904 is replaced by glutamine, an amino acid with highly similar properties. This variant was not reported in population-based cohorts in the following databases: Database of Single Nucleotide Polymorphisms (dbSNP), NHLBI Exome Sequencing Project (ESP) and 1000 Genomes Project. Based on protein sequence alignment, this amino acid position is poorly conserved in available vertebrate species. In addition, this alteration is predicted to be possibly damaging by PolyPhen but tolerated by SIFT in silico analyses. Since supporting evidence is limited at this time, the clinical significance of p.E904Q remains unclear. |
Invitae | RCV000229677 | SCV000289764 | uncertain significance | Hereditary breast ovarian cancer syndrome | 2016-03-27 | criteria provided, single submitter | clinical testing | In summary, this variant is a rare missense change with uncertain impact on protein function. It has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). This variant is not present in population databases (rs80357035, ExAC no frequency) and has not been reported in the literature in individuals with a BRCA1-related disease. ClinVar contains an entry for this variant (Variation ID: 141808). This sequence change replaces glutamic acid with glutamine at codon 904 of the BRCA1 protein (p.Glu904Gln). The glutamic acid residue is weakly conserved and there is a small physicochemical difference between glutamic acid and glutamine. |
Color Diagnostics, |
RCV000130465 | SCV000537567 | uncertain significance | Hereditary cancer-predisposing syndrome | 2019-03-27 | criteria provided, single submitter | clinical testing | |
University of Washington Department of Laboratory Medicine, |
RCV000130465 | SCV003849408 | likely benign | Hereditary cancer-predisposing syndrome | 2023-03-23 | criteria provided, single submitter | curation | Missense variant in a coldspot region where missense variants are very unlikely to be pathogenic (PMID:31911673). |